254751-10-5Relevant articles and documents
CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREOF
-
Paragraph 0073; 0081, (2019/04/05)
Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.
LINKED CYCLIC COMPOUND AS CASPASE INHIBITOR
-
Paragraph 0057; 0061, (2019/12/05)
A compound represented by formula (I), a pharmaceutically acceptable salt or tautomer thereof, and an application of the compound as a caspase inhibitor.
CASPASE INHIBITORS BASED ON PYRIDAZINONE SCAFFOLD
-
Page/Page column 8, (2010/03/04)
The present invention relates to a pyridazinone derivative which can be used as a caspase inhibitor, process for the preparation thereof, and pharmaceutical composition for inhibiting caspase comprising the same.